EIM
NVCR icon

Essex Investment Management’s NovoCure NVCR Stock Holding History

Essex Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93M Buy
+452,370
New +$5.65M 0.78% 38
2025
Q2 		– Sell
-121,040
Closed -$2.16M – 317
2025
Q1 		$2.16M Sell
121,040
-786
-0.6% -$17.9K 0.45% 97
2024
Q4 		$3.63M Sell
121,826
-40,111
-25% -$849K 0.65% 49
2024
Q3 		$2.53M Buy
161,937
+451
+0.3% +$8.18K 0.44% 100
2024
Q2 		$2.77M Buy
+161,486
New +$2.84M 0.52% 72
2021
Q3 		– Sell
-17,036
Closed -$3.78M – 435
2021
Q2 		$3.78M Sell
17,036
-7,250
-30% -$1.41M 0.44% 71
2021
Q1 		$3.21M Buy
24,286
+2,987
+14% +$472K 0.39% 79
2020
Q4 		$3.69M Sell
21,299
-10,535
-33% -$1.44M 0.46% 65
2020
Q3 		$3.54M Sell
31,834
-6,028
-16% -$482K 0.51% 45
2020
Q2 		$2.25M Sell
37,862
-1,506
-4% -$99K 0.37% 82
2020
Q1 		$2.65M Sell
39,368
-1,459
-4% -$115K 0.54% 47
2019
Q4 		$3.44M Buy
40,827
+1,500
+4% +$121K 0.42% 62
2019
Q3 		$2.94M Sell
39,327
-14,693
-27% -$1.17M 0.42% 62
2019
Q2 		$3.42M Sell
54,020
-53,489
-50% -$2.71M 0.47% 47
2019
Q1 		$5.18M Sell
107,509
-37,159
-26% -$1.79M 0.77% 25
2018
Q4 		$4.84M Sell
144,668
-24,459
-14% -$894K 0.76% 25
2018
Q3 		$8.86M Buy
169,127
+4,550
+3% +$181K 1.04% 14
2018
Q2 		$5.15M Sell
164,577
-795
-0.5% -$22.1K 0.64% 34
2018
Q1 		$3.6M Sell
165,372
-5,865
-3% -$126K 0.47% 54
2017
Q4 		$3.46M Buy
171,237
+88,753
+108% +$1.71M 0.46% 54
2017
Q3 		$1.64M Buy
+82,484
New +$1.62M 0.22% 151

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Essex Investment Management's NVCR Position: Q1 2026 in Review

Essex Investment Management opened a new position in NovoCure (NVCR) in Q1 2026: 452,370 shares worth $4.93M. The stake represents 0.78% of the portfolio and ranks #38 among its holdings. This is a return to the name: Essex Investment Management previously reported a position in NVCR as recently as Q1 2025.

Essex Investment Management first reported a position in NVCR in Q3 2017 and has held it in 21 quarters since. The position peaked at $8.86M in Q3 2018. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Essex Investment Management held 452,370 shares of NovoCure worth $4.93M as of Q1 2026.
  • NovoCure was a new Essex Investment Management position in Q1 2026.
  • NovoCure made up 0.78% of Essex Investment Management's portfolio in Q1 2026, its #38 holding.
  • Essex Investment Management first reported a position in NovoCure in Q3 2017 and has held it in 21 quarters since.
  • Essex Investment Management's NovoCure position peaked at $8.86M in Q3 2018.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.